Produkty 1257742-38-3

CAS 1257742-38-3 występuje w naszej ofercie pod nazwami: 18-Hydroxycorticosterone-9,11,12,12-d4, 18-HYDROXYCORTICOSTERONE-9,11,12,12-D4,&, 18-Hydroxycorticosterone-d4. Oferty producentów: Biosynth, Sigma-Aldrich, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 1 mg.

18-Hydroxycorticosterone-9,11,12,12-d4
Biosynth
  • opakowanie: 1mg
  • Warianty: 1
Zobacz produkt
18-HYDROXYCORTICOSTERONE-9,11,12,12-D4,&
Sigma-Aldrich
  • opakowanie: 1MG
  • Warianty: 1
od 19095,00
Zobacz produkt
18-Hydroxycorticosterone-d4
Chemat, MedChemExpress
  • opakowanie: 1mg, 1 mg
  • Warianty: 2
od 42835,51
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9S,10R,11S,13R,14S,17S)-9,11,12,12-tetradeuterio-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-one (CAS 1257742-38-3) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 366.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13R,14S,17S)-9,11,12,12-tetradeuterio-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-one. InChIKey: HFSXHZZDNDGLQN-NREATFFYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O5
Masa molowa366.5 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13R,14S,17S)-9,11,12,12-tetradeuterio-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-one
InChIKeyHFSXHZZDNDGLQN-NREATFFYSA-N
SMILES[2H][C@]12[C@@H](CCC3=CC(=O)CC[C@@]31C)[C@@H]4CC[C@@H]([C@]4(C([C@]2([2H])O)([2H])[2H])CO)C(=O)CO

Dane obliczone przez PubChem (NCBI)

Synonimy: 18-Hydroxycorticosterone-d4, 18-Hydroxycorticosterone-9,11,12,12-d4, orb2300194, 18-Hydroxycorticosterone-[2H4], 18-Hydroxycorticosterone-9,11,12,12-d4, >=98 atom % D, >=95% (CP)
Powiązane formy tego związku
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
Izomery (ten sam wzór sumaryczny)
6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5
(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H30O5
2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C21H30O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O5
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5